Article Details

Amphivena Therapeutics lands $62 mln Series C

Retrieved on: 2019-09-23 22:37:30

Tags for this article:

Click the tags to see associated articles and topics

Amphivena Therapeutics lands $62 mln Series C. View article details on hiswai:

Excerpt

<div>... cell engager therapeutics for cancer, has raised $62 million in Series C financing. NanoDimension and <b>Qiming Venture Partners</b> USA led the round.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up